Literature DB >> 86017

Prevention of antiblastic neutropenia with lithium carbonate.

U Visca, F Mensi, M P Spina, R Bombara, B Giraldi, A Massari, F Rossi, G Santi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 86017     DOI： 10.1016/s0140-6736(79)91233-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Biological response modifiers and differentiation inducers. Current status in cancer research.

Authors:  P Reizenstein; G Mathé
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

2.  Haematological effects of lithium and its use in treatment of neutropenia.

Authors:  A J Barrett
Journal:  Blut       Date:  1980-01

3.  The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

Authors:  Versha Banerji; Stacey M Frumm; Kenneth N Ross; Loretta S Li; Anna C Schinzel; Cynthia K Hahn; Rose M Kakoza; Kwan T Chow; Linda Ross; Gabriela Alexe; Nicola Tolliday; Haig Inguilizian; Ilene Galinsky; Richard M Stone; Daniel J DeAngelo; Giovanni Roti; Jon C Aster; William C Hahn; Andrew L Kung; Kimberly Stegmaier
Journal:  J Clin Invest       Date:  2012-02-13       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.